SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION ARTICLE M impact

Odyssey Therapeutics reports positive OD-001 Phase 2a results

Odyssey Therapeutics said OD-001 met Phase 2a success criteria and reported $433 million in cash, expected to fund operations into H2 2028.

ODTX

Odyssey Therapeutics reported positive Phase 2a OD-001 results and a $433 million cash balance expected to fund operations into H2 2028.Key Highlights:Original SEC Filing: Odyssey Therapeutics, Inc. [ ODTX ] - 8-K - Sep. 08, 2026This is an AI-powered summary. It may contain inaccuracies.

Consider v…

Related stories